Novel compounds which modulate PPAR-type receptors have the following general formula (I):
and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
调节
PPAR型受体的新化合物具有以下一般式(I),并制成适合于人类或兽医药学(在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢有关的领域)的药物组合物,或制成化妆品组合物。